Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Neuroscience and Behavioral Physiology

25-04-2024 | Alzheimer's Disease

Intranasal delivery of human Wharton’s jelly-derived mesenchymal stem cells alleviates Aβ-induced Alzheimer’s symptoms in rat models by regulating neurotrophic and apoptotic factors

Authors: Ebrahim Eslami, Farshid Ghiyamihoor, Marjan Sadr, Marziyeh Ajdary, Sahar Hakimpour, Rana Mehdizadeh, Ronak Shabani, Mehdi Mehdizadeh

Published in: Neuroscience and Behavioral Physiology

Login to get access

Abstract

Alzheimer's disease (AD) is the most common cause of dementia in adulthood, followed by cognitive and behavioral deficits. Today, mesenchymal stem cell (MSC)-based therapy is a suitable therapeutic option to improve regenerative medicine approaches against neurodegenerative disorders, including AD. This study aimed to investigate the effects of human Wharton’s jelly-derived MSCs (WJ-MSCs) on AD-like rat models (rats treated with amyloid beta 1-42 (Aβ1-42)) by evaluating the expression of neurotrophic factors such as brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF), as well as the expression of apoptotic factors such as B-cell lymphoma 2 (BCL2, an anti-apoptotic factor to inhibit apoptosis) and BCL2-associated X protein (BAX, a pro-apoptotic factor to regulate apoptosis). After treatment of AD rat models with WJ-MSCs, behavioral tests (i.e., passive avoidance and Morris water maze) showed cognitive improvements, and amelioration of cells in the CA1 area of the hippocampus was detected by cresyl violet staining. Additionally, real-time polymerase chain reaction (RT-PCR) of the hippocampus indicated an increase in the expression level of the BDNF, NGF, and BCL2 genes and a decrease in the expression level of the BAX gene. Overall, the WJ-MSCs improved the cognitive function in AD rat models by increasing the neurotrophic and anti-apoptotic factors and decreasing the pro-apoptotic factor.

Graphical Abstract

This graphical abstract depicts the process of isolating mesenchymal stem cells (MSCs) from human Wharton’s jelly (WJ) and their subsequent use in an Alzheimer’s disease (AD) rat model. The left side of the image illustrates the steps involved in isolating MSCs from WJ. The right side of the image shows how AD rat models are generated under stereotaxic injection of Aβ. In the middle, intranasally administration of MSCs is shown and then how their effects are evaluated using behavioral tests, nissl staining, and RT-qPCR.
Appendix
Available only for authorised users
Literature
Ahmed, N. E.-M. B., Murakami, M., Hirose, Y., & Nakashima, M. (2016). Therapeutic potential of dental pulp stem cell secretome for Alzheimer’s disease treatment: an in vitro study. Stem Cells International, 2016.CrossRef
Aisen, P. S., Cummings, J., & Schneider, L. S. (2012). Symptomatic and nonamyloid/tau based pharmacologic treatment for Alzheimer disease. Cold Spring Harbor perspectives in medicine, 2(3), a006395.CrossRefPubMedPubMedCentral
Alipour, M., Nabavi, S. M., Arab, L., Vosough, M., Pakdaman, H., Ehsani, E., & Shahpasand, K. (2019). Stem cell therapy in Alzheimer’s disease: possible benefits and limiting drawbacks. Molecular biology reports, 46(1), 1425-1446.CrossRefPubMed
Balashova, A., Pershin, V., Zaborskaya, O., Tkachenko, N., Mironov, A., Guryev, E., … Mukhina, I. (2019). Enzymatic digestion of hyaluronan-based brain extracellular matrix in vivo can induce seizures in neonatal mice. Frontiers in neuroscience, 13, 1033.
Barati, E., Asl, S. S., Jamshidian, M., & Shahidi, S. (2016). Effect of Borage on hipocampal TNF-α protein and gene in the Amyloid β-Peptide (25–35)-Induced of Alzheimer model in rat. Biosciences Biotechnology Research Asia, 13(1), 37-42.CrossRef
Beigi Boroujeni, F., Pasbakhsh, P., Mortezaee, K., Pirhajati, V., Alizadeh, R., Aryanpour, R., … Ragerdi Kashani, I. (2020). Intranasal delivery of SDF‐1α‐preconditioned bone marrow mesenchymal cells improves remyelination in the cuprizone‐induced mouse model of multiple sclerosis. Cell biology international, 44(2), 499-511.
Blondiaux, A., Jia, S., Annamneedi, A., Çalışkan, G., Nebel, J., Montenegro-Venegas, C., … Stork, O. (2023). Linking epileptic phenotypes and neural extracellular matrix remodeling signatures in mouse models of epilepsy. Neurobiology of disease, 188, 106324.
Blurton-Jones, M., Kitazawa, M., Martinez-Coria, H., Castello, N. A., Müller, F.-J., Loring, J. F., … LaFerla, F. M. (2009). Neural stem cells improve cognition via BDNF in a transgenic model of Alzheimer disease. Proceedings of the National Academy of Sciences, 106(32), 13594-13599.
Chen, S.-D., Wu, C.-L., Hwang, W.-C., & Yang, D.-I. (2017). More insight into BDNF against neurodegeneration: anti-apoptosis, anti-oxidation, and suppression of autophagy. International journal of molecular sciences, 18(3), 545.CrossRefPubMedPubMedCentral
Choi, J. M., Park, H. S., He, M. T., Kim, Y. S., Kim, H. Y., Lee, A. Y., & Cho, E. J. (2022). Membrane-Free Stem Cells and Pyridoxal 5′-Phosphate Synergistically Enhance Cognitive Function in Alzheimer’s Disease Mouse Model. Antioxidants, 11(3), 601.CrossRefPubMedPubMedCentral
Danielyan, L., Schäfer, R., von Ameln-Mayerhofer, A., Buadze, M., Geisler, J., Klopfer, T., … Ayturan, M. (2009). Intranasal delivery of cells to the brain. European journal of cell biology, 88(6), 315-324.
Donders, R., Bogie, J. F., Ravanidis, S., Gervois, P., Vanheusden, M., Marée, R., … Gijbels, K. (2018). Human Wharton's Jelly-Derived Stem Cells Display a Distinct Immunomodulatory and Proregenerative Transcriptional Signature Compared to Bone Marrow-Derived Stem Cells. Stem cells and development, 27(2), 65-84.
Dragunow, Μ., MacGibbon, G., Lawlor, P., Butterworth, N., Connor, B., Henderson, C., … Faull, R. (1997). Apoptosis, neurotrophic factors and neurodegeneration. Reviews in the Neurosciences, 8(3-4), 223-265.
Faghani, M., Ejlali, F., Sharifi, Z. N., Molladoost, H., & Movassaghi, S. (2016). The Neuroprotective Effect of Atorvastatin on Apoptosis of Hippocampus Following Transient Global Ischemia/Reperfusion. Galen Medical Journal, 5(2), 82-89.
Girotra, P., Behl, T., Sehgal, A., Singh, S., & Bungau, S. (2022). Investigation of the molecular Role of brain-derived neurotrophic factor in Alzheimer’s disease. Journal of Molecular Neuroscience, 72(2), 173-186.CrossRefPubMed
Hour, F. Q., Moghadam, A. J., Shakeri-Zadeh, A., Bakhtiyari, M., Shabani, R., & Mehdizadeh, M. (2020). Magnetic targeted delivery of the SPIONs-labeled mesenchymal stem cells derived from human Wharton's jelly in Alzheimer's rat models. Journal of Controlled Release.
Hsieh, J.-Y., Wang, H.-W., Chang, S.-J., Liao, K.-H., Lee, I.-H., Lin, W.-S., … Cheng, S.-M. (2013). Mesenchymal stem cells from human umbilical cord express preferentially secreted factors related to neuroprotection, neurogenesis, and angiogenesis. PloS one, 8(8).
Jahanshahi, M., Shabani, R., Nikmahzar, E., & Babakordi, F. (2014). Female rat hippocampal cell density after conditioned place preference. Folia Biologica (Czech Republic), 60(1), 47-51.
Jiao, S., Shen, L., Zhu, C., Bu, X., Liu, Y., Liu, C., … Walker, D. (2016). Brain-derived neurotrophic factor protects against tau-related neurodegeneration of Alzheimer’s disease. Translational psychiatry, 6(10), e907-e907.
Joyce, N., Annett, G., Wirthlin, L., Olson, S., Bauer, G., & Nolta, J. A. (2010). Mesenchymal stem cells for the treatment of neurodegenerative disease. Regenerative medicine, 5(6), 933-946.CrossRefPubMed
Kolf, C. M., Cho, E., & Tuan, R. S. (2007). Mesenchymal stromal cells: biology of adult mesenchymal stem cells: regulation of niche, self-renewal and differentiation. Arthritis research & therapy, 9(1), 204.CrossRef
Lee, I.-S., Jung, K., Kim, I.-S., Lee, H., Kim, M., Yun, S., … Park, K. I. (2015). Human neural stem cells alleviate Alzheimer-like pathology in a mouse model. Molecular neurodegeneration, 10(1), 38.
Lee, N. K., Park, S. E., Kwon, S. J., Shim, S., Byeon, Y., Kim, J.-H., … Chang, J. W. (2017). Agouti related peptide secreted via human mesenchymal stem cells upregulates proteasome activity in an Alzheimer’s disease model. Scientific reports, 7(1), 1-9.
Lo Furno, D., Mannino, G., & Giuffrida, R. (2018). Functional role of mesenchymal stem cells in the treatment of chronic neurodegenerative diseases. Journal of cellular physiology, 233(5), 3982-3999.CrossRefPubMed
Madadi, S., & Mehdizaded, M. (2014). Alzheimer diseases. Avicenna Journal of Neuro Psych Physiology, 1(2).
Mattson, M. P. (2000). Apoptosis in neurodegenerative disorders. Nature reviews Molecular cell biology, 1(2), 120-130.CrossRefPubMed
Mattson, M. P., Maudsley, S., & Martin, B. (2004). BDNF and 5-HT: a dynamic duo in age-related neuronal plasticity and neurodegenerative disorders. Trends in neurosciences, 27(10), 589-594.CrossRefPubMed
Mehdizadeh, M., Dabaghian, F. H., Shojaee, A., Molavi, N., Taslimi, Z., Shabani, R., & Asl, S. S. (2017). Protective effects of cyperus rotundus extract on amyloid β-peptide (1-40)-induced memory impairment in male rats: a behavioral study. Basic and clinical neuroscience, 8(3), 249.CrossRefPubMedPubMedCentral
Mendoza-Naranjo, A., Contreras-Vallejos, E., Henriquez, D. R., Otth, C., Bamburg, J. R., Maccioni, R. B., & Gonzalez-Billault, C. (2012). Fibrillar amyloid-β 1-42 modifies actin organization affecting the cofilin phosphorylation state: a role for Rac1/cdc42 effector proteins and the slingshot phosphatase. Journal of Alzheimer's disease, 29(1), 63-77.CrossRefPubMed
Morris, R. (1984). Developments of a water-maze procedure for studying spatial learning in the rat. Journal of neuroscience methods, 11(1), 47-60.CrossRefPubMed
Morris, R. G., Garrud, P., Rawlins, J. a., & O'Keefe, J. (1982). Place navigation impaired in rats with hippocampal lesions. Nature, 297(5868), 681-683.CrossRefPubMed
Mungmunpuntipantip, R., & Wiwanitkit, V. (2022). Brain-derived neurotrophic factor and its clinical applications. Medical Journal of Dr. DY Patil University, 15(5), 619-628.
Pang, S., Li, S., Cheng, H., Luo, Z., Qi, X., Guan, F., … Gao, X. (2023). Discovery of an evodiamine derivative for PI3K/AKT/GSK3β pathway activation and AD pathology improvement in mouse models. Frontiers in Molecular Neuroscience, 15, 1025066.
Park, S. E., Lee, N. K., Na, D. L., Chang, J. W., & Chang, J. W. (2018). Optimal mesenchymal stem cell delivery routes to enhance neurogenesis for the treatment of Alzheimer’s disease. Histology and histopathology: cellular and molecular biology, 33(6), 533-541.PubMed
Pickford, F., Masliah, E., Britschgi, M., Lucin, K., Narasimhan, R., Jaeger, P. A., … Levine, B. (2008). The autophagy-related protein beclin 1 shows reduced expression in early Alzheimer disease and regulates amyloid β accumulation in mice. The Journal of clinical investigation, 118(6), 2190-2199.
Qin, C., Bai, L., Li, Y., & Wang, K. (2022a). The functional mechanism of bone marrow-derived mesenchymal stem cells in the treatment of animal models with Alzheimer’s disease: crosstalk between autophagy and apoptosis. Stem cell research & therapy, 13(1), 1-13.CrossRef
Qin, C., Wang, K., Zhang, L., & Bai, L. (2022b). Stem cell therapy for Alzheimer’s disease: An overview of experimental models and reality. Animal models and experimental medicine, 5(1), 15-26.CrossRefPubMedPubMedCentral
Qiyami Hour, F., Shabani, R., Ashtrai, B., Moinzadeh, A., & Mehdizadeh, M. Labelling of human Wharton's jelly‐derived mesenchymal stem cells with gold nanorods by biomimicry method. Cell Biochemistry and Function.
Radi, E., Formichi, P., Battisti, C., & Federico, A. (2014). Apoptosis and oxidative stress in neurodegenerative diseases. Journal of Alzheimer's disease, 42(s3), S125-S152.CrossRefPubMed
Ranjbaran, H., Abediankenari, S., Mohammadi, M., Jafari, N., Khalilian, A., Rahmani, Z., … Ebrahimi, P. (2018). Wharton's jelly derived-mesenchymal stem cells: Isolation and characterization. Acta Medica Iranica, 28-33.
Ribeiro, C. A., Fraga, J. S., Grãos, M., Neves, N. M., Reis, R. L., Gimble, J. M., … Salgado, A. J. (2012). The secretome of stem cells isolated from the adipose tissue and Wharton jelly acts differently on central nervous system derived cell populations. Stem cell research & therapy, 3(3), 18.
Salehi, M. S., Jurek, B., Karimi-Haghighi, S., Nezhad, N. J., Mousavi, S. M., Hooshmandi, E., … Miyan, J. A. (2022). Intranasal application of stem cells and their derivatives as a new hope in the treatment of cerebral hypoxia/ischemia: a review. Reviews in the Neurosciences.
Sampaio, T. B., Savall, A. S., Gutierrez, M. E. Z., & Pinton, S. (2017). Neurotrophic factors in Alzheimer's and Parkinson's diseases: implications for pathogenesis and therapy. Neural regeneration research, 12(4), 549.CrossRefPubMedPubMedCentral
Shaabani, R., Jahanshahi, M., Nowrouzian, M., Sadeghi, Y., & Azami, N. (2011). Effect of morphine based CPP on the hippocampal astrocytes of male Wistar rats. Asian Journal of Cell Biology, 6(3), 89-96.CrossRef
Shahror, R. A., Wu, C.-C., Chiang, Y.-H., & Chen, K.-Y. (2019). Tracking Superparamagnetic Iron Oxide-labeled Mesenchymal Stem Cells using MRI after Intranasal Delivery in a Traumatic Brain Injury Murine Model. JoVE (Journal of Visualized Experiments)(153), e60450.
Sharma, V. K., Singh, T. G., Singh, S., Garg, N., & Dhiman, S. (2021). Apoptotic pathways and Alzheimer’s disease: probing therapeutic potential. Neurochemical Research, 46(12), 3103-3122.CrossRefPubMed
Simorgh, S., Alizadeh, R., Shabani, R., Karimzadeh, F., Seidkhani, E., Majidpoor, J., … Kasbiyan, H. (2021a). Olfactory mucosa stem cells delivery via nasal route: a simple way for the treatment of Parkinson disease. Neurotoxicity Research, 39(3), 598-608.
Simorgh, S., Bagher, Z., Farhadi, M., Kamrava, S. K., Boroujeni, M. E., Namjoo, Z., … Alizadeh, R. (2021b). Magnetic targeting of human olfactory mucosa stem cells following intranasal administration: a novel approach to Parkinson’s disease treatment. Molecular Neurobiology, 58, 3835-3847.
Tamtaji, O. R., Hosseinzadeh, H., Talaei, S. A., Behnam, M., Firoozeh, S. M. T., Taghizadeh, M., & Alipoor, R. (2017). Protective Effects of Red Onion (Allium cepa) Ethanolic Extract on Learning and Memory Impairments in Animal Models of Diabetes. Galen Medical Journal, 6(3), 249-257.CrossRef
Tang, Y., Han, L., Bai, X., Liang, X., Zhao, J., Huang, F., & Wang, J. (2020). Intranasal Delivery of Bone Marrow Stromal Cells Preconditioned with Fasudil to Treat a Mouse Model of Parkinson’s Disease. Neuropsychiatric Disease and Treatment, 16, 249.CrossRefPubMedPubMedCentral
Teixeira, F. G., Carvalho, M. M., Sousa, N., & Salgado, A. J. (2013). Mesenchymal stem cells secretome: a new paradigm for central nervous system regeneration? Cellular and Molecular Life Sciences, 70(20), 3871-3882.CrossRefPubMed
Tuszynski, M. H., Thal, L., Pay, M., Salmon, D. P., Bakay, R., Patel, P., … . Tong, G. (2005). A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease. Nature medicine, 11(5), 551-555.
Vafaee, F., Zarifkar, A., Emamghoreishi, M., Namavar, M. R., Shahpari, M., & Zarifkar, A. H. (2018). Effect of Recombinant Insulin-like Growth Factor-2 Injected into the Hippocampus on Memory Impairment Following Hippocampal Intracerebral Hemorrhage in Rats. Galen Medical Journal, 7, 1353.CrossRef
van Rijzingen, I. M., Gispen, W. H., & Spruijt, B. M. (1995). Olfactory bulbectomy temporarily impairs Morris maze performance: an ACTH (4–9) analog accellerates return of function. Physiology & behavior, 58(1), 147-152.CrossRef
Wozniak, D. F., Hartman, R. E., Boyle, M. P., Vogt, S. K., Brooks, A. R., Tenkova, T., … Muglia, L. J. (2004). Apoptotic neurodegeneration induced by ethanol in neonatal mice is associated with profound learning/memory deficits in juveniles followed by progressive functional recovery in adults. Neurobiology of disease, 17(3), 403-414.
Wu, C.-C., Lien, C.-C., Hou, W.-H., Chiang, P.-M., & Tsai, K.-J. (2016). Gain of BDNF function in engrafted neural stem cells promotes the therapeutic potential for Alzheimer’s disease. Scientific reports, 6(1), 27358.CrossRefPubMedPubMedCentral
Wu, S., Sasaki, A., Yoshimoto, R., Kawahara, Y., Manabe, T., Kataoka, K., … Yuge, L. (2008). Neural stem cells improve learning and memory in rats with Alzheimer’s disease. Pathobiology, 75(3), 186-194.
Yang, H., Liu, Y., Liu, X., Gu, H., Zhang, J., & Sun, C. (2020). Concise Review: The Regulatory Mechanism of Lysine Acetylation in Mesenchymal Stem Cell Differentiation. Stem Cells International, 2020.
Yu-Taeger, L., Stricker-Shaver, J., Arnold, K., Bambynek-Dziuk, P., Novati, A., Singer, E., … Riess, O. (2019). Intranasal administration of mesenchymal stem cells ameliorates the abnormal dopamine transmission system and inflammatory reaction in the R6/2 mouse model of Huntington disease. Cells, 8(6), 595.
Metadata
Title
Intranasal delivery of human Wharton’s jelly-derived mesenchymal stem cells alleviates Aβ-induced Alzheimer’s symptoms in rat models by regulating neurotrophic and apoptotic factors
Authors
Ebrahim Eslami
Farshid Ghiyamihoor
Marjan Sadr
Marziyeh Ajdary
Sahar Hakimpour
Rana Mehdizadeh
Ronak Shabani
Mehdi Mehdizadeh
Publication date
25-04-2024
Publisher
Springer International Publishing
Published in
Neuroscience and Behavioral Physiology
Print ISSN: 0097-0549
Electronic ISSN: 1573-899X
DOI
https://doi.org/10.1007/s11055-024-01582-1